Dengue viruses cluster antigenically but not as discrete serotypes
- PMID: 26383952
- PMCID: PMC4876809
- DOI: 10.1126/science.aac5017
Dengue viruses cluster antigenically but not as discrete serotypes
Abstract
The four genetically divergent dengue virus (DENV) types are traditionally classified as serotypes. Antigenic and genetic differences among the DENV types influence disease outcome, vaccine-induced protection, epidemic magnitude, and viral evolution. We characterized antigenic diversity in the DENV types by antigenic maps constructed from neutralizing antibody titers obtained from African green monkeys and after human vaccination and natural infections. Genetically, geographically, and temporally, diverse DENV isolates clustered loosely by type, but we found that many are as similar antigenically to a virus of a different type as to some viruses of the same type. Primary infection antisera did not neutralize all viruses of the same DENV type any better than other types did up to 2 years after infection and did not show improved neutralization to homologous type isolates. That the canonical DENV types are not antigenically homogeneous has implications for vaccination and research on the dynamics of immunity, disease, and the evolution of DENV.
Trial registration: ClinicalTrials.gov NCT00473135 NCT00831012 NCT00920517.
Copyright © 2015, American Association for the Advancement of Science.
Figures
Similar articles
-
Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity.Cell Host Microbe. 2021 Nov 10;29(11):1634-1648.e5. doi: 10.1016/j.chom.2021.09.006. Epub 2021 Oct 4. Cell Host Microbe. 2021. PMID: 34610295 Free PMC article.
-
Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.J Virol. 2021 Jan 28;95(4):e00658-20. doi: 10.1128/JVI.00658-20. Print 2021 Jan 28. J Virol. 2021. PMID: 33208445 Free PMC article.
-
Live attenuated tetravalent dengue virus host range vaccine is immunogenic in African green monkeys following a single vaccination.J Virol. 2014 Jun;88(12):6729-42. doi: 10.1128/JVI.00541-14. Epub 2014 Apr 2. J Virol. 2014. PMID: 24696467 Free PMC article.
-
Morphological Diversity and Dynamics of Dengue Virus Affecting Antigenicity.Viruses. 2021 Jul 24;13(8):1446. doi: 10.3390/v13081446. Viruses. 2021. PMID: 34452312 Free PMC article. Review.
-
Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.Front Immunol. 2019 Jun 11;10:1316. doi: 10.3389/fimmu.2019.01316. eCollection 2019. Front Immunol. 2019. PMID: 31244855 Free PMC article. Review.
Cited by
-
Antigenic cartography reveals complexities of genetic determinants that lead to antigenic differences among pandemic GII.4 noroviruses.Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):e2015874118. doi: 10.1073/pnas.2015874118. Proc Natl Acad Sci U S A. 2021. PMID: 33836574 Free PMC article.
-
Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine.PLoS Negl Trop Dis. 2020 Sep 21;14(9):e0008676. doi: 10.1371/journal.pntd.0008676. eCollection 2020 Sep. PLoS Negl Trop Dis. 2020. PMID: 32956362 Free PMC article.
-
Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development.Biomed J. 2020 Aug;43(4):375-387. doi: 10.1016/j.bj.2020.06.003. Epub 2020 Jun 6. Biomed J. 2020. PMID: 32611537 Free PMC article.
-
Evaluation of cell-surface displayed synthetic consensus dengue EDIII cells as a potent oral vaccine candidate.Microb Cell Fact. 2018 Sep 14;17(1):146. doi: 10.1186/s12934-018-0994-8. Microb Cell Fact. 2018. PMID: 30217208 Free PMC article.
-
Differential replicative fitness of the four dengue virus serotypes circulating in Colombia in human liver Huh7 cells.Braz J Infect Dis. 2020 Jan-Feb;24(1):13-24. doi: 10.1016/j.bjid.2019.11.003. Epub 2019 Dec 13. Braz J Infect Dis. 2020. PMID: 31843340 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- HHSN272201400008C/AI/NIAID NIH HHS/United States
- Z99 AI999999/ImNIH/Intramural NIH HHS/United States
- 089276/WT_/Wellcome Trust/United Kingdom
- HHSN272201000040I/AI/NIAID NIH HHS/United States
- P01 AI106695/AI/NIAID NIH HHS/United States
- DP1 OD000490/OD/NIH HHS/United States
- R01 AI099631/AI/NIAID NIH HHS/United States
- MR/K021885/1/MRC_/Medical Research Council/United Kingdom
- 100891/WT_/Wellcome Trust/United Kingdom
- DP1-OD000490-01/OD/NIH HHS/United States
- HHSN266200700010C/AI/NIAID NIH HHS/United States
- HHSN272201000040I/HHSN27200004/D04/PHS HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases